๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network

โœ Scribed by Wallace Crandall; Michael D. Kappelman; Richard B. Colletti; Ian Leibowitz; John E. Grunow; Sabina Ali; Howard I. Baron; James H. Berman; Brendan Boyle; Stanley Cohen; Fernando del Rosario; Lee A. Denson; Lynn Duffy; Mark J. Integlia; Sandra C. Kim; David Milov; Ashish S. Patel; Bess T. Schoen; Dorota Walkiewicz; Peter Margolis


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
625 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background: There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes.

Methods:

The ImproveCareNow Network was established under the sponsorship of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the American Board of Pediatrics as a prototype for a model of improving subspecialty care that included three components: 1) creating enduring multicenter collaborative networks of pediatric subspecialists, 2) sharing of performance data collected in patient registries, and 3) training in quality improvement. The network began with a focus on improving initial diagnostic testing and evaluation, the classification of the severity and extent of disease, the detection and treatment of inadequate nutrition and growth, and the appropriate dosing of immunomodulator medications. Changes are based on an evidence-based model of chronic illness care involving the use of patient registries for population management, previsit planning, decision support, promoting self-management, and auditing of care processes.

Results: Currently, patients are being enrolled at 23 sites.

Through 2009, data have been analyzed on over 2500 patients from over 7500 visits. Initial results suggest improvements in both care processes (e.g., appropriate medication dosing and completion of a classification bundle that includes the patient's diagnosis, disease activity, distribution and phenotype, growth status, and nutrition status) and outcomes (e.g., the percentage of patients in remission).

Conclusions: These improvements suggest that practice sites are learning how to apply quality improvement methods to improve the care of patients.


๐Ÿ“œ SIMILAR VOLUMES


Development of process and outcome measu
โœ Wallace V. Crandall; Brendan M. Boyle; Richard B. Colletti; Peter A. Margolis; M ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 320 KB

The Institute of Medicine's publications, To Err is Human and Crossing the Quality Chasm, publicized the widespread deficits in healthcare quality. The quality of care in inflammatory bowel disease (IBD) has not been comprehensively evaluated, in part due to a lack of well-established IBD measures o

Development of extraintestinal manifesta
โœ Folashade Adebisi Jose; Elizabeth A. Garnett; Eric Vittinghoff; George D. Ferry; ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 211 KB ๐Ÿ‘ 2 views

Background: Extraintestinal manifestations (EIMs) in pediatric patients with inflammatory bowel disease (IBD) are poorly characterized. We examined the prevalence of EIMs at diagnosis, subsequent incidence, and risk factors for EIMs. ## Methods: Data for 1649 patients from the PediIBD Consortium

Epidemiology of pediatric inflammatory b
โœ Eric I. Benchimol; Kyle J. Fortinsky; Peter Gozdyra; Meta Van den Heuvel; Johan ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 418 KB ๐Ÿ‘ 1 views

Background: Temporal trends in the incidence of pediatriconset inflammatory bowel disease (IBD) are controversial and a wide range of estimates have been reported worldwide. We conducted a systematic review of research describing the epidemiology of childhood-onset IBD to assess changes in incidence

Role of diet in the development of infla
โœ Christine A. Chapman-Kiddell; Peter S.W. Davies; Lynda Gillen; Graham L. Radford ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 135 KB ๐Ÿ‘ 1 views

The inflammatory bowel diseases (IBDs) are a group of heterogeneous disorders characterized by acute and chronic inflammatory changes in the small or large bowel, or in both. Increasing incidence and prevalence figures for IBD both in the developed and developing world indicate that environmental fa

Immunogenecity of hepatitis A vaccine in
โœ Andrzej Radzikowski; Aleksandra Banaszkiewicz; Izabella ลazowska-Przeorek; Urszu ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 421 KB ๐Ÿ‘ 2 views

Background: There are only a few studies on immune response to routine vaccinations in children with inflammatory bowel disease (IBD), despite a strong need for this kind of study. The aim of the study was to evaluate the immunogenicity of an inactivated hepatitis A vaccine (HAV) in IBD pediatric pa